Amicus Therapeutics (FOLD) Jumps: Stock Up 20.7% - Tale of the Tape - Amicus Therapeutics (NASDAQ:FOLD), Regeneron Pharmaceuticals (NASDAQ:REGN)

Amicus Therapeutics, Inc. FOLD was a big mover last session, as its shares rose nearly 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 10, as the stock is now trading above the volatile price range of $1.82 to $2.15.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Amicus Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the medical sector include TrovaGene, Inc. TROV, ZIOPHARM Oncology, Inc. ZIOP and Regeneron Pharmaceuticals, Inc. REGN. All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

AMICUS THERAPT FOLD: Free Stock Analysis Report

REGENERON PHARM REGN: Free Stock Analysis Report

TROVAGENE INC TROV: Get Free Report

ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs